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Aims.ToinvestigatetheassociationofC-reactiveprotein(CRP)andgammaglutamyltransferase(GGT)concentrationswithnewly
diagnosed diabetes deﬁned by either glucose or HbA1c criteria in Chinese adults. Methods. A population-based cross-sectional
study was conducted in 2006. Data from 1167 men and 1607 women aged 35–74 years were analyzed. Diabetes was deﬁned
according to either glucose or HbA1c criteria alone. Results. Compared with nondiabetes, multivariate-adjusted OR (95%CI) was
1.13 (0.90,1.42) in men and 1.21 (1.00,1.45) in women for CRP and 1.42 (1.18,1.72) and 1.57 (1.31,1.87) for GGT, respectively.
Neither CRP nor GGT was associated with the presence of diabetes deﬁned by the HbA1c criterion. Conclusions. The eﬀect of
elevatedCRPondiabetesdeﬁnedbytheglucosecriterionwasmediatedthroughobesity,butelevatedGGTwasanindependentrisk
factor for diabetes in this Chinese population. None of the two was, however, associated with the elevated HbA1c concentrations.
1.Introduction
A new large Chinese national survey [1] is in consistent with
previous report from China [2] showing that type 2 diabetes
has become a seriously public health threat in China. The
studies suggest that China is taking over India and becoming
the epicenter of diabetes in the world. In these previous
studies, type 2 diabetes has been deﬁned according to fasting
(FPG) and/or 2-hour plasma glucose criteria after ingesting
75g oral glucose load (OGTT) [3]. Recently haemoglobin
A1c (HbA1c) test has been adopted as a diagnostic criterion
for diabetes [4]. The impact of changes in diagnostic criteria
on prevalence of diabetes and diﬀerences in phenotypes
detected by diﬀerent criteria are, however, still less known.
C-reactive protein (CRP) is a nonspeciﬁc biomarker
of acute inﬂammation and is produced primarily in the
liver. Several prospective studies had shown that serum
CRP accelerate or increase the development of diabetes
[5–9], particularly in women [8, 9]. There is increasing
evidence showing that liver enzymes, such as gamma-
glutamyltransferase (GGT), used as a marker of alcohol
consumption or liver disease, show a dose-response relation
with incident diabetes even within its normal range [10]a n d
mayalsopredictthedevelopmentofdiabetesinbothgenders
independent of traditionally risk factors [11, 12].
However, type 2 diabetes in all above-mentioned studies
was diagnosed by FPG and/or OGTT not by HbA1c criteria.
In this study, the association of CRP or GGT with type2 Experimental Diabetes Research
2 diabetes diagnosed by either glucose or HbA1c criteria
is investigated based on a cross-sectional population-based
Chinese study in Qingdao, China.
2.SubjectsandMethods
2.1. Study Population. A total of 6100 individuals aged 35–74
years who had lived in Qingdao City for at least 5 years were
recruited in 2006 with stratiﬁed random cluster sampling
from3urbandistricts(Shinan,ShibeiandSifang)and3rural
districts (Huangdao, Jiaonan and Jimo). Among these, 5355
individuals participated in the study, with a response rate
of 87.8%. The inclusion criteria for the current study were
(1) newly diagnosed diabetes by both FPG and/or 2 hours
plasma glucose criteria (2) no data missing for body mass
index (BMI), waist circumference (WC), blood pressure
measurements, CRP, GGT, and HbA1c. A total of 2774 (1167
men) subjects with full required information were included.
Height and weight were measured with participants
wearing light clothes and without shoes, and BMI was
calculated by dividing weight (Kg) by height (m) squared.
WC was measured at the middle point between the rib cage
and top of the iliac crest to the nearest 0.1cm. Three consec-
utive blood pressure readings, apart by at least 30 seconds,
were taken from the right arm of seated subjects, and the
average of the three readings was used in the data analysis.
Smoking status was classiﬁed as current smokers (smoking
daily regardless of the amount and type of smoking) and
nonsmokers (including ex-smoking, smoking now and then
and not smoking at all). Alcohol-drinking status was deﬁned
as current drinkers (drink frequently regardless of the
amount and type of alcohol) and nondrinkers (including
ex-drinking, drinking now and then or not drinking at
all). Family history of diabetes was deﬁned as having at
least one of parents, sibling or oﬀspring with diabetes.
School years were divided into two levels (≤9o r>9s c h o o l
years). Occupational activities were categorized into light
(managerial staﬀ), moderate (teacher/doctor/nurse), and
heavy(workerorfarmer).Allsubjectswithoutapriorhistory
ofdiabetesunderwentastandardOGTT.Bloodsampleswere
transported in a dark box with ice to the laboratory no more
than 6 hours after drawing and stored at −80◦C. The lab
assays were performed in the central laboratory of Qingdao
Hiser Medical Center using Olympus AU analyzers (Olym-
pus, Tokyo, Japan). Plasma glucose levels were determined
by the glucose oxidase method. Fasting serum triglycerides
(TG) and total cholesterol (TC) were determined by enzy-
matic method while fasting serum CRP and high-density
lipoprotein cholesterol (HDL-C) by direct method. Low-
density lipoprotein cholesterol (LDL-C) was calculated using
the Friedewald equation. GGT and alanine aminotransferase
(ALT) were measured by using an International Federation
of Clinical Chemistry (IFCC) method. HbA1c was measured
using an immunoturbidimetry method (Tina-qu.a A1C HIT
917 large; Roche Diagnostics). The HbA1c concentration
was calculated by using the formula provided by Roche
Diagnostics: [calculated HbA1c (%) = 0.81 × HbA1c (test
result) + 2.39] to match the values with those found in the
new IFCC standardization procedure, a conventional high
performance liquid chromatography (HPLC) method [13].
The calculated HbA1c was subsequently used in the data
analysis. The reference range for the calculated HbA1c was
4.3%–5.8%. Fasting insulin concentration was measured in
2125individualsusingthechemiluminescenceimmunoassay
method (Abbott AxSym). Fatty Liver Index (FLI)-based
on GGT, TG, BMI and WC-, was calculated as follows
[14]:
FLI = (e0.953∗loge (triglycerides) + 0.139∗BMI +
0.718∗loge (ggt) +0.053∗waist circumference − 15.745)/(1
+ e0.953∗loge (triglycerides) + 0.139∗B M I+0 . 7 1 8 ∗loge
(ggt) + 0.053∗waist circumference − 15.745)∗100.
An FLI ≤ 30 rules out and an FLI ≥ 60 indicates hepatic
steatosis as detected by ultrasoundgraphy.
The Ethics Committee of Qingdao Municipal Hospital
approved the study. Verbal or written consent was obtained
from each participant prior to the data collection.
2.2. Classiﬁcation of Diabetes. Diabetes was deﬁned accord-
ing to the 2006 World Health Organization (WHO)/Inter-
national Diabetes Federation (IDF) criteria [3]a n dI n t e r -
national Expert Committee Report on the role of the
HbA1c assay for diabetes [4]. Subjects who reported a
history of diabetes and who were under treatment with
either insulin or oral antidiabetic agents were considered
as previously diagnosed diabetes, regardless of their fasting
plasma glucose levels. Diagnosed diabetes was excluded
from the data analysis to reduce the potential eﬄuence
of the anti-diabetic medications and the diabetic com-
plications. Newly diagnosed diabetes was deﬁned if there
was an FPG level of ≥7.0mmol/L and/or 2hPG level
of ≥11.1mmol/L regardless of the HbA1c concentration.
Alternatively, newly diagnosed diabetes was determined
if the calculated HbA1c ≥6.5% in spite of the glucose
levels. Waist circumference ≥90cm for Chinese men and
≥80cm for Chinese women was deﬁned as central obesity
according to the 2004 IDF deﬁnition of metabolic syndrome
[15].
2.3. Statistical Analysis. A chi-square test for categorical
variables and the general linear model (GLM) procedure
for continuous variables were used to compare diﬀerences
in prevalence and in age-adjusted means among diﬀerent
glucose categories. The linear association of CRP and GGT
with plasma glucose and HbA1c was tested using linear
regression model adjusting for age, school years, family
history of diabetes, WC, LDL, TG, and SBP. Stepwise
logistic regression analysis was performed to estimate the
odds ratio (OR) and 95% conﬁdence intervals (CI) for
the prevalence of diabetes corresponding to a one standard
deviation (SD) increase in continuous variables. Age, school
years, alcohol-drinking, smoking, family history of diabetes,
BMI, SBP, LDL, TG, TC, CRP and GGT were ﬁtted in the
multivariate model. For all analyses, variables with skewed
distribution, such as CRP, and GGT, were log transformed
before data analysis. All analyses were performed using
SPSS (Version 15.0; SPSS Inc, Chicago, IL, USA). A P-
value less than .05 (two tailed) was considered statistically
signiﬁcant.Experimental Diabetes Research 3
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Table 2: Standard β coeﬃcients for C-reactive protein (CRP) and
gamma-glutamyltransferase (GGT) in association with fasting, 2
hours plasma glucose concentrations (mmol/L) and HbA1c (%) in
individuals without a prior history of diabetes.
Fasting plasma
glucose
2h o u r sp l a s m a
glucose HbA1c
Men (n = 1167)
CRP (mg/dL) 0.03 0.04 0.03
GGT (U/L) 0.02 0.11∗ 0.03
Women (n = 1607)
CRP (mg/dL) 0.08∗ 0.10† 0.06∗
GGT (U/L) 0.15† 0.12† 0.04
Adjusted for age, school years, family history of diabetes, waist circum-
ference, systolic blood pressure, triglycerides, and low density lipoprotein
cholesterol. CRP and GGT are logarithmic transformed. ∗P <. 01, †P <
.001.
3. Results
The baseline characteristics of the study population were
summarized in Table 1. The respective prevalence of newly
diagnosed diabetes by glucose or HbA1c criteria was 13.1%
versus 10.5% in men and 11.4% versus 10.0% in women.
Compared with individuals without diabetes by glucose
criterion, those with newly diagnosed diabetes were older
and more obese, hypertensive, dyslipidemia, and insulin
resistant in men and in women. They also had signiﬁcantly
higher geometric mean of GGT and CRP. Family history
of diabetes was more common in patients with diabetes
than in those without it. Current smoking and alcohol-
drinking made no diﬀerence between diabetic and non-
diabeticgroupsofeithergender.Incomparisonwithsubjects
without diabetes by HbA1c criterion, those with newly
diagnosed diabetes by HbA1c criterion had higher serum
FPG, 2hPG, HDL, TC, and fasting insulin levels in men and
higherWC,serumFPG,2hPG,CRP,andfastinginsulinlevels
in women. There was no diﬀerence in GGT concentrations
between diabetes and non-diabetes deﬁned by the HbA1c
criterion.
The correlation coeﬃcients for CRP were statistically
signiﬁcant with either glucose levels or HbA1c levels in
women but not in men, whereas those for GGT were
signiﬁcantwith2hPGinbothmenandwomenandwithFPG
in women only (Table 2).
The OR for newly diagnosed diabetes by the glucose
criterion were signiﬁcantly higher for GGT but not for CRP
in men and women, which was, however, not observed for
newly diagnosed diabetes by the HbA1c criterion (Table 3).
B u ti nt h ep r e s e n ts t u d y ,a nH b A 1 Cl e v e lo f6 . 5 %r e c -
ommended by the International Expect Committee has a
sensitivity and speciﬁcity of 33.5% and 87.8% among the
participants. According to our previous report [16], the
optimal HbA1C cutoﬀ point for newly diagnosed diabetes in
this study population was 5.6%, which was lower than the
recommended value of 6.5%. By taking a cutoﬀ of 5.6% with
the sensitivity of 74.2% and speciﬁcity of 65.2%, the OR for
newly diagnosed diabetes by the HbA1c criterion remained
unsigniﬁcant for CRP and GGT in men and women. There
was a signiﬁcant interaction of the WC with the CRP (P =
.039) and with the GGT (P<. 001) in women, but not
in men. A stratiﬁed analysis by the WC levels was, thus,
performed to check whether the association between the
CRP (or GGT) and diabetes was mediated through obesity.
The results showed that the CRP was associated with the
presence of diabetes only in obese women, not in women
with low WC. The GGT was positively associated with
diabetes in spite of the WC levels in both men and women
(Table 3). In a subgroup of individuals with fasting insulin
measures (sample size = 2125), the analysis was also made
by ﬁtting fasting insulin into the stepwise logistic model.
After ﬁtting with fasting insulin, the OR for newly diagnosed
diabetes by the glucose criterion were signiﬁcantly higher for
GGT in men (OR = 1.33, 1.05–1.69) and in women (OR =
1.47, 1.18–1.72) but for CRP only in obese women (OR =
1.23,1.04–1.56),whichweresimilarwiththeresultsfromthe
model without fasting insulin within the same subgroup of
individuals.
The prevalence of an FLI of ≥60 is 25.5% in men and
9.6% in women in our present study, and elevated serum
GGT levels was associated with diabetes in both low (FLI
<60) (OR = 1.02, 1.01–1.03) and high (FLI ≥ 60 ) (OR =
1.07, 1.02–1.18) FLI groups.
4. Conclusions
In this population-based cross-sectional Chinese study, we
found that the elevated GGT concentrations were indepen-
dently associated with the presence of diabetes deﬁned by the
glucose criterion in both men and women, while the eﬀect of
elevated CRP was signiﬁcant only in obese women. Diabetes
deﬁned by the HbA1c criterion was associated with none of
the two.
Previous studies led to conﬂicting results as to whether
there was an association of serum CRP levels with type 2
diabetes. Cross-sectional [8] and longitudinal studies [9]
have shown a positive association between the CRP and
diabetes in women but not in men. A hazard ratio of 7.60
(95% CI [4.43, 13.04]) for incidence of diabetes wasreported
in women in the MONICA/KORA Augsburg case-cohort
study [9]. Another study in Hoorn in the Netherlands with
only 140 men and 139 women revealed an independent
association in men but not in women with incidence of
diabetes [5]. In the Hisayama study in Japan, increased
CRP level was a signiﬁcant predictor of incident diabetes in
both genders in the general Japanese population [7], and
in the Hong Kong Cardiovascular Risk Factors Prevalence
Study, CRP was found to independently predict the risk of
progressing to diabetes in Chinese with IGT, but the data was
not separately analyzed by genders due to the small sample
size [6].
Recent studies demonstrated that elevated serum CRP
levels were associated with obesity and insulin resistance
[17,18].ThesestudiessuggestedthattheeﬀectoftheCRPon
plasma glucose levels was mediated via obesity and insulin
resistance. First, some studies have shown that reductionsExperimental Diabetes Research 5
Table 3: Odds ratio (95% CI) for newly diagnosed diabetes corresponding to a one-standard deviation increase in continuous variables
stratiﬁed by waist circumference categories. Only the variables entered into the ﬁnal logistic regression model are presented.
Standard
deviation
FPG ≥7.0 mmol/L
and/or 2hPG
≥11.1mmol/L
OR (95% CI)
HbA1c ≥6.5%
OR (95% CI)
HbA1c ≥5.6%∗
OR (95% CI)
Men
Waist circumference <90 (cm)
(n = 671)
Age (year) 10.41 1.46 (1.12,1.89) — —
Positive family history of diabetes — 3.04 (1.60,5.77) — —
Gamma-glutamyltransferase (U/L) 0.72 1.59 (1.29,1.96) — —
Systolic blood pressure (mmHg) 19.25 1.38 (1.08,1.76) — 1.30 (1.10,1.53)
Total cholesterol (mmol/L) 1.03 — 1.32(1.04,1.66) —
School years >9( ≤9) — — 0.59(0.34,0.98) —
Waist circumference ≥90 (cm)
(n = 496)
Age (year) 10.41 1.62 (1.21,2.19) — —
Positive family history of diabetes — 2.42 (1.28,4.58) — —
Low-density lipoprotein cholesterol
(mmol/L) 0.97 1.61 (1.23,2.10) — 1.61 (1.28,2.02)
Triglyceride (mmol/L) 1.10 1.64 (1.26,2.14) — —
School years >9( ≤9) — — 0.46 (0.25,0.85) —
Body mass index (kg/m2) 2.52 — 1.50 (1.05,2.15) 1.27 (1.01,1.60)
Smoking — — 2.29 (1.24,4.22) —
All (n = 1167)
Age (year) 10.41 1.65 (1.37,1.99) — —
Positive family history of diabetes — 2.35 (1.50,3.66) — —
Gamma-glutamyltransferase (U/L) 0.72 1.42 (1.18,1.72) — —
Low-density lipoprotein cholesterol
(mmol/L) 0.97 1.26 (1.06,1.49) — 1.32 (1.17,1.49)
Triglyceride (mmol/L) 1.10 1.30 (1.11,1.52) — —
School years >9( ≤9) — — 0.50 (0.34,0.74) —
Total cholesterol (mmol/L) 1.03 — 1.24 (1.04,1.47) —
Women
Waist circumference <80 (cm)
(n = 667)
Age (year) 9.74 1.75 (1.26, 2.44) — —
Positive family history of diabetes — 2.42 (1.12,5.21) — —
Gamma-glutamyltransferase (U/L) 0.54 1.83 (1.32,2.54) — —
School years >9( v e r s u s≤9) — — 0.31 (0.15,0.64) —
Systolic blood pressure (mmHg) 22.42 — — 1.34 (1.09,1.64)
Waist circumference ≥80 (cm)
n = 940)
Age (year) 9.74 1.47 (1.19,1.82) — 1.19 (1.04,1.36)
C-reactive protein 1.02 1.30 (1.11,1.51) — —
Gamma-glutamyltransferase (U/L) 0.54 1.56 (1.27,1.91) — —
Systolic blood pressure (mmHg) 22.42 1.22 (1.02,1.48) — —
Triglyceride (mmol/L) 0.80 1.57 (1.30,1.89) — —
School years >9( v e r s u s≤9) — — 0.44 (0.26,0.75) —
All (n = 1607)
Age (year) 9.74 1.44 (1.19,1.73) — 1.15 (1.02,1.28)6 Experimental Diabetes Research
Table 3: Continued.
Standard
deviation
FPG ≥7.0 mmol/L
and/or 2hPG
≥11.1mmol/L
OR (95% CI)
HbA1c ≥6.5%
OR (95% CI)
HbA1c ≥5.6%∗
OR (95% CI)
Positive family history of diabetes — 1.66 (1.09,2.51) — —
Gamma-glutamyltransferase
(U/L) 0.54 1.57 (1.31,1.87) — —
C-reactive protein (mg/dl) 1.02 1.21 (1.00,1.45) — —
Low-density lipoprotein
cholesterol (mmol/L) 0.92 1.22 (1.04,1.43) — 1.16 (1.04,1.29)
Triglyceride (mmol/L) 0.80 1.48 (1.26,1.74) — —
Systolic blood pressure (mmHg) 22.42 1.26 (1.06,1.49) — 1.30 (1.10,1.53)
School years >9( ≤9) — — 0.36 (0.23,0.55) —
Age, body mass index, gamma-glutamyltransferase, low-density lipoprotein cholesterol, triglyceride, total cholesterol, C-reactive protein, systolic blood
pressure, family history of diabetes, school years, smoking, and alcohol-drinking are ﬁtted in the models.C-reactive protein and gamma-glutamyltransferase
were logarithmic transformed. ∗Optimal cutoﬀ value for diagnosis of diabetes in this study population [16].
in CRP levels were strongly correlated with the amount
of weight loss, suggesting a direct link between CRP and
obesity [19]. Thus, obesity-triggered inammation could have
ag r e a t e re ﬀect on the pathogenesis of type 2 diabetes.
Second, some studies have shown that CRP, a sensitive
marker of chronically subclinical inﬂammation, emerged to
be part of the insulin resistance syndrome and an important
factor in the pathogenesis of diabetes [17]. Several possible
reasons might explain our ﬁnding that CRP was associated
with diabetes only in obese women, and the main factors are
presumably sex diﬀerences regarding body composition and
sex hormone levels. First, the correlation between CRP and
W Cw a ss t r o n g e ri nw o m e nt h a ni nm e n( 0 . 2 5v e r s u s0 . 1 1 )
in our study; moreover, women have a higher percentage
of body fat than men [20], especially in obese women, so
CRP may have a greater role in the development of insulin
resistance and type 2 diabetes in women. Second, there may
be an interaction between endogenous sex hormones and
subclinical inﬂammation with the risk factors of diabetes
[21, 22].
Our observation that elevated GGT was an indepen-
dently risk factor for diabetes by the glucose criterion
in both men and women in this Chinese population is
in line with results from some other studies [11, 12],
which were performed in the general population. Several
possible mechanisms may explain how GGT levels aﬀect
the development of diabetes. First, high GGT levels may
indicate fat deposition in the liver which often causes hepatic
insulin resistance, further systemic insulin resistance and
hyperinsulinaemia [23, 24]. Thus, GGT could be a marker
of the insulin resistance syndrome. Second, GGT plays an
important role in the defensive response to oxidative stress.
It is noteworthy that hyperglycemia, such as that shown by
IGT/IFG, can induce the predominance of oxidative stress
over antioxidative defense systems. The oxidative stress can
contribute to more pronounced hyperglycemia, with this
vicious cycle ﬁnally ending by inducing diabetes [25]. Third,
inﬂammation may be one of the mechanisms, and one
study showed that elevated serum GGT levels could be the
expression ofsubclinical inﬂammation [26],whichalsoleads
to the pathogenesis of type 2 diabetes.
In a cohort of Korean adults, fatty liver, as assessed
by ultrasound, was predictive of diabetes independent of
other risk factors [27], and a fatty liver index calculated
b a s e do nl e v e l so fG G T ,T G ,B M I ,a n dW Cc o u l dp r e d i c t
the development of diabetes during a followup of a French
cohort [28]. Elevation of the GGT has been considered to
be a marker of the fatty liver and reported to precede the
development of diabetes in a number of prospective studies
[29, 30]. Our study showed that the association of GGT
with type 2 diabetes was independent of the fatty liver index.
However, whether the fatty liver index derived from a case-
control Italian study can accurately assess the presence of the
fatty liver in a Chinese population is not known and need to
be further investigated.
It is noteworthy that GGT, as a diabetes risk factor, is
less important than a positive family history of diabetes and
elevated waist circumference, which have been included in a
simple Qingdao Diabetes Risk Score derived from the study
population [31]. But GGT may be a useful marker to study
the pathogenesis of diabetes. The study also revealed that
the phenotypes of diabetes diagnosed by glucose criteria may
diﬀerfromthatbytheHbA1ccriteria,whichrequiresfurther
investigation.
The study has several strengths. First, all diabetic subjects
were newly diagnosed according to standard 2-hour OGTT
criteria or HbA1c criteria; previously diagnosed diabetes
were excluded to avoid the impact of the hypoglycaemic
medications, modiﬁcation in lifestyles, and the duration of
diabetes which might reduce the weight of the patients.
Second, this is a population-based study which is a represen-
tative of the Chinese population in general. The sample size
islargeenoughtoenabledataanalysisseparatelyformenand
women.
However, several limitations should be considered. First,
since the current study was cross-sectional, it was notExperimental Diabetes Research 7
possible to establish the causality between elevated serum
CRP/GGT and type 2 diabetes. Second, an ultrasound-
graphic scan to assess the fatty liver was not performed in the
current study, and the possible association of the fatty liver
with the presence of diabetes, and with the elevated GGT
could not be accurately explored. The fatty liver index is only
a surrogate measure of the fatty liver but not validated in a
Chinese population yet.
In summary, the eﬀect of elevated CRP on diabetes
deﬁned by the glucose criteria was mediated through obesity,
butelevatedGGTwasanindependentriskfactorfordiabetes
by the glucose criteria in this Chinese population. None of
the two was, however, associated with the diabetes diagnosed
by HbA1c criterion. The diﬀerences in the results between
diﬀerent criteria may reﬂect the fact that diabetic individuals
deﬁned by diﬀerent criteria may have diﬀerent phenotypic
and prognostic characteristics. This is worthy to be further
investigated with prospective studies. The contribution of
obesity and fatty liver needs also to be further investigated.
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